268 results on '"Chajon E"'
Search Results
2. Review of clinical applications of radiation-enhancing nanoparticles
3. Head-and-Neck MRI-only radiotherapy treatment planning: From acquisition in treatment position to pseudo-CT generation
4. Implementation of an optimization method for parotid gland sparing during inverse planning for head and neck cancer radiotherapy
5. Radiothérapie en conditions stéréotaxiques du carcinome hépatocellulaire : résultats d’une étude rétrospective multicentrique
6. PET-based prognostic survival model after radiotherapy for head and neck cancer
7. A density assignment method for dose monitoring in head-and-neck radiotherapy
8. Contraintes de doses aux organes à risque en radiothérapie conformationnelle et stéréotaxique : intestin grêle et duodénum
9. A PET-based nomogram for oropharyngeal cancers
10. ITV versus mid-ventilation for treatment planning in lung SBRT: a comparison of target coverage and PTV adequacy by using in-treatment 4D cone beam CT
11. Voxel-based identification of local recurrence sub-regions from pre-treatment PET/CT for locally advanced head and neck cancers
12. 3-Dimensional Volumetric Distribution and Dispersion Analysis of the Radioenhancer NBTXR3 in Various Solid Malignancies
13. The role of imaging in adaptive radiotherapy for head and neck cancer
14. Safety of NBTXR3 Radioenhancer Delivery in Liver Metastases
15. 489P Analysis of 3-dimensional volumetric distribution and dispersion of the radioenhancer NBTXR3 in various solid malignancies
16. Radiothérapie guidée par l’image et adaptative
17. Planification selon la position moyenne du cycle respiratoire : modèle de planification optimale pour une distribution de dose dans les tumeurs pulmonaires
18. De la radiothérapie guidée par l’image à la radiothérapie guidée par la dose
19. Exérèse chirurgicale des métastases pulmonaires de cancer colorectal : quelle stratégie en 2014 ?
20. Quelle RCMI ? Du « step and shoot » au VMAT : point de vue du physicien
21. PH-0159: NANORAY-103: Phase I/II trial of NBTXR3 activated by SBRT in patients with HCC and liver metastases
22. PH-0278: Schedule of irradiation impacts the overall survival in case of SBRT for stage I NSCLC
23. 993P NBTXR3 radiation enhancing hafnium oxide nanoparticles: RP2D for the treatment of HCC and liver metastases
24. CBCT dose calculation in head and neck adaptive radiotherapy accuracy assessment of four methods
25. Adaptive radiotherapy in head and neck cancer to correct tumor underdose and parotid gland overdose
26. Validation of transit EPID and application for Head and Neck adaptive radiotherapy
27. Characterization of recurrence origin using pre-treatment PET/CT for head and neck cancers
28. 47 Comparison of a deep learning method with three other methods to perform dose calculation from CBCT images in head-and-neck radiotherapy
29. Phase I/II trial of NBTXR3 activated by SBRT in patients with hepatocellular carcinoma or liver metastasis
30. Hafnium oxide nanoparticles activated by SBRT: a new interventional radiation therapy approach for the treatment of unresectable liver cancers
31. EP-1936 PET/CT Radiomics predict local recurrence in patients treated with SBRT for early-stage NSCLC
32. EP-1414 SBRT for the treatment of hepatocellular carcinoma: a retrospective multicenter study
33. Difference in Toxicity between HIV-Positive and HIV-Negative Patients with Squamous-Cell Cancer of the Anal Canal Treated with Concomitant Radio-Chemotherapy
34. 1 Comparison of target coverage for two motion-encompassing methods for lung stereotactic body radiotherapy by using in-treatment 4D cone-beam CT
35. A density assignment method for dose monitoring in head-and-neck radiotherapy
36. Adaptive radiotherapy for head and neck cancer
37. Radiothérapie en conditions stéréotaxiques du carcinome hépatocellulaire : étude rétrospective multicentrique
38. Hepatocellular carcinoma and liver metastasis treated by hafnium oxide nanoparticles activated by stereotactic body radiation therapy
39. PET-based prognostic survival model after radiotherapy for head and neck cancer
40. A phase I/II trial of hafnium oxide nanoparticles activated by radiotherapy in hepatocellular carcinoma and liver metastasis
41. Adaptive radiotherapy in head and neck cancer is required to avoid tumor underdose
42. EP-1386: Impact of the stereotactic irradiation schedule for non-small-cell lung carcinoma stage I
43. PV-0428: Adaptive radiotherapy in head and neck cancer to correct tumor underdose and parotid gland overdose
44. PO-0962: CBCT dose calculation in head and neck adaptive radiotherapy: accuracy assessment of four methods
45. PO-0889: Validation of transit EPID and application for Head & Neck adaptive radiotherapy
46. EP-1172: Characterization of recurrence origin using pre-treatment PET/CT for head and neck cancers
47. Impact du schéma d’irradiation dans le cadre d’une irradiation en conditions stéréotaxiques des carcinomes bronchiques non à petites cellules de stade I
48. Évaluation du degré de difficulté de la réalisation des séances de radiothérapie en conditions stéréotaxiques robotisée hépatique : analyses des facteurs associés à la qualité de la séance
49. Quantification de la dose cumulée délivrée aux parotides, avec ou sans replanification, à partir de tomographies coniques
50. Radiothérapie adaptive des cancers ORL : bénéfice sur la couverture du volume tumoral
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.